Charafe-Jauffret Emmanuelle, Ginestier Christophe, Iovino Flora, Wicinski Julien, Cervera Nathalie, Finetti Pascal, Hur Min-Hee, Diebel Mark E, Monville Florence, Dutcher Julie, Brown Marty, Viens Patrice, Xerri Luc, Bertucci François, Stassi Giorgio, Dontu Gabriela, Birnbaum Daniel, Wicha Max S
Centre de Recherche en Cancérologie de Marseille, Laboratoire d'Oncologie Moléculaire, UMR891 Inserm/Institut Paoli-Calmettes, Université de la Méditerranée, Marseille, France.
Cancer Res. 2009 Feb 15;69(4):1302-13. doi: 10.1158/0008-5472.CAN-08-2741. Epub 2009 Feb 3.
Tumors may be initiated and maintained by a cellular subcomponent that displays stem cell properties. We have used the expression of aldehyde dehydrogenase as assessed by the ALDEFLUOR assay to isolate and characterize cancer stem cell (CSC) populations in 33 cell lines derived from normal and malignant mammary tissue. Twenty-three of the 33 cell lines contained an ALDEFLUOR-positive population that displayed stem cell properties in vitro and in NOD/SCID xenografts. Gene expression profiling identified a 413-gene CSC profile that included genes known to play a role in stem cell function, as well as genes such as CXCR1/IL-8RA not previously known to play such a role. Recombinant interleukin-8 (IL-8) increased mammosphere formation and the ALDEFLUOR-positive population in breast cancer cell lines. Finally, we show that ALDEFLUOR-positive cells are responsible for mediating metastasis. These studies confirm the hierarchical organization of immortalized cell lines, establish techniques that can facilitate the characterization of regulatory pathways of CSCs, and identify potential stem cell markers and therapeutic targets.
肿瘤可能由具有干细胞特性的细胞亚成分引发并维持。我们利用通过ALDEFLUOR检测评估的醛脱氢酶表达,来分离和鉴定源自正常和恶性乳腺组织的33个细胞系中的癌症干细胞(CSC)群体。33个细胞系中有23个含有ALDEFLUOR阳性群体,该群体在体外和NOD/SCID异种移植中均表现出干细胞特性。基因表达谱分析确定了一个413基因的CSC谱,其中包括已知在干细胞功能中起作用的基因,以及诸如CXCR1/IL-8RA等以前未知发挥此类作用的基因。重组白细胞介素-8(IL-8)增加了乳腺癌细胞系中的乳腺球形成和ALDEFLUOR阳性群体。最后,我们表明ALDEFLUOR阳性细胞负责介导转移。这些研究证实了永生化细胞系的层次组织,建立了有助于表征CSC调控途径的技术,并鉴定了潜在的干细胞标志物和治疗靶点。